Why have this procedure done in China specifically?

China offers advanced stem cell technology at a fraction of Western costs—this comprehensive 4-week programme is priced around $18,000, significantly lower than comparable protocols abroad. Chinese hospitals have high patient volumes, providing extensive clinical experience with UC-MSC therapies for neurological conditions. Additionally, regulatory oversight ensures quality-controlled stem cell products, and many facilities specialize in integrated neurorehabilitation, combining cutting-edge cellular therapy with evidence-based rehabilitation under one roof.